Piramal Pharma Solutions (PPS), the Contract Development and Manufacturing Organization (CDMO) business of Piramal Pharma
Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635) has released its Sustainability Report 2025–26, highlighting
Piramal Pharma Limited has completed the acquisition of an additional 40.67% stake in Yapan Bio
Piramal Pharma, one of the prominent names in the pharmaceutical industry, has announced a remarkable
Piramal Pharma, one of the prominent names in the pharmaceutical industry, has announced a remarkable
